Elevance Health Inc. (ELV) Tops Q2 EPS by 25c

Elevance Health Inc. (NYSE: ELV) reported Q2 EPS of $9.04, $0.25 better than the analyst estimate of $8.79. Revenue for the quarter came in at $43.4 billion versus the consensus estimate of $41.64 billion.

For earnings history and earnings-related data on Elevance Health Inc. (ELV) click here.

You May Also Be Interested In

• 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
• MIND Technology (MIND) Misses Q1 EPS by 5c
• Adobe Systems (ADBE) Tops Q2 EPS by 14c, Offers Guidance